Odonate Therapeutics, Inc. (NasdaqGS:ODT) announces a share repurchase program. Under the program, the company will repurchase up to 20,000,000 shares, representing 51.95% of its outstanding share capital. The shares will be repurchased in order to return capital to stockholders. As of September 30, 2021, the company had 38,500,000 shares in outstanding.